MUMBAI (Reuters) - Shares in GlaxoSmithKline Pharmaceuticals Ltd surged as much as 20 percent after GlaxoSmithKline Plc (GSK) said on Monday it plans to buy up to 20.6 million shares to raise its stake in its Indian unit.
GSK is offering to buy the shares at 3,100 rupees per share, a premium of 26 percent over the market price on Friday, in a deal worth up to 629 million pounds that would raise its stake in GlaxoSmithKline Pharmaceuticals to up to 75 percent from 50.7 percent.
(Reporting by Abhishek Vishnoi; Editing by Supriya Kurane)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app